HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
41 hedge funds and large institutions have $40.5M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 1 closing their positions.
2,400% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 1
869% more capital invested
Capital invested by funds: $4.18M → $40.5M (+$36.3M)
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
141% more funds holding
Funds holding: 17 → 41 (+24)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.36M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.17M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.45M |
| 5 |
PWP
Private Wealth Partners
Mill Valley,
California
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$81K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.26K |
HTGM Hedge Fund Activity: Q1 2018 in Review
41 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q1 2018, worth a combined $40.5M — up 869% from $4.18M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HTGM positions and 1 closed out — a net gain of 24 holders — while 9 added to existing stakes and 1 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.6M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $81K sold.
- 41 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q1 2018, up from 17 in Q4 2017.
- Funds reported $40.5M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q1 2018, up 869% quarter-over-quarter.
- 25 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q1 2018 and 1 closed out, a net change of +24 holders.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q1 2018 was Fidelity Investments, an estimated $11.6M added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q1 2018 was Oxford Asset Management, an estimated $81K sold.
Based on aggregated 13F filings for Q1 2018.